SAFEGUARDS AGAINST OTC ZOVIRAX MISUSE
This article was originally published in The Tan Sheet
Executive Summary
SAFEGUARDS AGAINST OTC ZOVIRAX MISUSE will include specific, "easy-to-read" instructions that inform consumers of the signs and symptoms of genital herpes and that stress the "importance of appropriate continuing medical attention," Burroughs Wellcome Senior Clinical Research Scientist Gray Davis, PhD, told an FDA public hearing on the proposed Rx-to-OTC switch. Patients also will be "warned" in product labeling "not to use the medication for any purpose" other than for genital herpes, Davis said.